Scientists from Bristol Myers Squibb developed a method using supercritical fluid chromatography for chiral bioanalysis.

$3.9 billion was wiped off Sepracor's market capitalization as investors called into question the entire utility of single enantiomers as a means of improving drugs and managing product life cycles.

These properties are however established when the material is grown, that is, the left- and right-handed enantiomers cannot be converted into one another without melting and recrystallization.